Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Duricef Capsules 500mg*


Contraindicated
Lack of data in pregnant women

Not recommended
Duricef Capsules 500mg* :
Type Medicine Non Marketed
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory GSK
Responsible Party Bristol-Myers Barceloneta Inc
Origin U.S.A.
Manufacturer Bristol-Myers Barceloneta Inc
Origin U.S.A.
ATC J01DB05
Revision Date 01/12/2010

Your comment will appear shortly after approval

Duricef Capsules 500mg* :

Revision Date : 01/12/2010


Effect Frequency
Agranulocytosis Rare
Allergic reaction Not known
Anaphylactic reactions Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Arthralgia (Pain joint) (Joint ache) Rare
Cholestasis Not known
Diarrhoea (Diarrhea) Rare
Dyspepsia Rare
Erythema multiforme Rare
Fever Not known
Genital candidiasis Not known
Hepatic dysfunction Rare
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Nausea Rare
Neutropenia Not known
Pruritus Not known
Pruritus genital Not known
Pseudomembranous colitis Not known
Serum sickness Rare
Skin rash Not known
Stevens-Johnson syndrome Rare
Thrombocytopenia (Thrombopenia) Rare
Transaminases increased Not known
Urticaria Not known
Vaginitis Not known
Vomiting Rare

Different Units By MoH Code

Revision Date : 01/04/2007

Duricef Capsules 500mg*  MoH 929 :
Form Capsule, hard
Package Size Box of 16
Strength 500mg
Storage Condition 15-30°C Away from moisture
NSSF ✘
Quarantine ✘
Reg. Number 135271
Submission date 01/01/1997
Registration Year 1997
Archived Date 2014


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info